Japanese test could ID Alzheimer’s earlier, spur new treatment pathways
By
Kimberly Marselas
Feb 01, 2018
A blood test that looks for biomarkers tied to Alzheimer’s disease could be the screening tool needed to identify patients earlier and get them into critical trials.
